APOE and Alzheimer disease: This analysis showed that levels of both HAGH (β = 0.477, P = 6.47 × 10−4) and CDH6 (β = 0.661, P = 1.48 × 10−4) proteins were significantly increased in AD patients compared to controls in APOE ε4 carriers.